Tranding
Hap2py Launches in Thailand, Uniting Profit with Purpose
Abracon Names Brian Holt Vice President of Global Sales
Possibilities and Opportunities: Seminar held in Hong Kong about ETF Connect in China Allocation
enreap becomes an official Atlassian Specialized Partner in ITSM
China's Miao embroidery dresses shine at Milan Fashion Week
2025-01-17 15:24:53

CUSMail

Medical/Pharmaceuticals

Gannex Announces Completion of the U.S. Phase I Trial of ASC43F, an In-House Developed First-in-Class Dual Targeting Fixed-dose Combination Tablet for NASH
Corporate/ 2023-07-23
Gannex Announces Completion of the U.S. ...

ASC43F was safe and well tolerated in healthy subjects with no clinically significant study drug related adverse events

AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH CONCURRENT CHEMORADIOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE III CLINICAL TRIAL FOR THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER
Corporate/ 2023-07-23
AKESO'S CADONILIMAB (PD-1/CTLA-4 BI...

HONG KONG,Jan. 4,2022-- Today,Akeso (09926.HK) announces that Cadonilimab (PD-1/ CTLA-4 bi-specific antibody),the first-inclass novel immuno...

Health / 2023-07-22
Breakthrough Discoveries on Novel Features of Om...
Corporate / 2023-07-23
Alamar Biosciences partners with Abcam to drive ...
Corporate / 2023-07-23
Harbour BioMed Announces Dosing of First Patient...
Corporate / 2023-07-23
Akeso's IL-17A MONOCLONAL ANTIBODY (GUMOKIM...
Health / 2023-07-22
Regor Therapeutics Announces U.S. FDA Authorizat...
Health / 2023-07-22
Muslim-Friendly Malaysia Showcases Healthcare Ex...
Corporate / 2023-07-23
EOFlow and Zihipp Announce Joint Venture for Dev...
Health / 2023-07-22
2020 Global Survey from ISAPS Sees Significant C...
Health / 2023-07-22
VISTA Eye Specialist resolved to be a Changemake...
Health / 2023-07-22
Biosyngen Pte Ltd launched biological production...
Corporate / 2023-07-23
Seegene Airlifts 1.7 million COVID-19 Tests to I...
Health / 2023-07-22
SyMap Medical Ltd. Announces its Strategic Colla...
Health / 2023-07-22
DoctorOnCall Offers Free Medical Assistance To F...
Health / 2023-07-22
iMEDISYNC UNVEILS WORLD'S FIRST INTEGRATED ...
Corporate / 2023-07-23
Antengene Announces First Patient Dosed in REACH...
Corporate / 2023-07-23
China Medical System (867.HK)'s Latest MSCI...
Corporate / 2023-07-23
Peijia Medical's New Milestone Asia's ...
Corporate / 2023-07-23
Akeso's PCSK9 MONOCLONAL ANTIBODY (EBRONUCI...

Follow Us

12,345 Fans 12,345 Followers
12,345 Connects 12,345 Followers
12,345 Subscribers 12,345 Followers

Newsletter

Join us to get the latest news.

Received instesting content ASAP

Tranding

News / 2023-11-05
Hap2py Launches in Thailand, Uniting Profit with Purpose
News / 2023-11-05
Abracon Names Brian Holt Vice President of Global Sales
News / 2023-11-05
Possibilities and Opportunities: Seminar held in Hong Ko
News / 2023-11-05
enreap becomes an official Atlassian Specialized Partner
Exhibition / 2023-09-26
China's Miao embroidery dresses shine at Milan Fash

Tags

Computer/ElectronicsBanking/Financial ServiceHealth Care/HospitalTelecommunicationsComputer SoftwareMedical/PharmaceuticalsEntertainmentRetailTransportationEnvironmental Products & Services

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

Categories

NewsBusinessGeneral BusinessFinancial ServicesExhibitionReal Estate and FurnitureAdvertising, Marketing MediaPolicy & Public InterestTechnologyAuto & TransportationBusiness TechnologyConsumer TechnologyEnergyEnvironmentTelecommunicationsHeavy Industry & ManufacturingCorporateEntertainmentLifeStyleTravelFoodsHealthSportsEducation

Tags

Fitness/WellnessArtificial IntelligenceSupply Chain/LogisticsGeneral ManufacturingCloud Computing / Internet of ThingsEnvironmentVoIPMutual FundsCannabisInfectious Disease ControlOTC/SmallCap IRWPublic InterestTobaccoBridal ServicesLegal Services

Quick Links

AboutAdvertisePrivacy & policyTerms & conditionsContact

© CUSMAIL. All Rights Reserved. Operate by Paid Release